SG11201606856SA - Modulation of cell growth and glycosylation in recombinant glycoprotein production - Google Patents

Modulation of cell growth and glycosylation in recombinant glycoprotein production

Info

Publication number
SG11201606856SA
SG11201606856SA SG11201606856SA SG11201606856SA SG11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA
Authority
SG
Singapore
Prior art keywords
glycosylation
modulation
cell growth
recombinant glycoprotein
glycoprotein production
Prior art date
Application number
SG11201606856SA
Other languages
English (en)
Inventor
Oliver Popp
Nicola Beaucamp
Georg Drabner
Stephanie Esslinger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201606856S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201606856SA publication Critical patent/SG11201606856SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201606856SA 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production SG11201606856SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (1)

Publication Number Publication Date
SG11201606856SA true SG11201606856SA (en) 2016-09-29

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606856SA SG11201606856SA (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Country Status (20)

Country Link
US (2) US20170058309A1 (hr)
EP (1) EP3110961B1 (hr)
JP (2) JP6831702B2 (hr)
KR (1) KR102280638B1 (hr)
CN (1) CN106133146B (hr)
BR (1) BR112016017660B1 (hr)
CA (1) CA2937611C (hr)
DK (1) DK3110961T3 (hr)
ES (1) ES2769003T3 (hr)
HR (1) HRP20200100T1 (hr)
HU (1) HUE047575T2 (hr)
LT (1) LT3110961T (hr)
MX (1) MX369395B (hr)
PL (1) PL3110961T3 (hr)
PT (1) PT3110961T (hr)
RS (1) RS59881B1 (hr)
RU (1) RU2712562C2 (hr)
SG (1) SG11201606856SA (hr)
SI (1) SI3110961T1 (hr)
WO (1) WO2015128314A1 (hr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013078106A1 (en) 2011-11-21 2013-05-30 Nonomura Arthur M Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same
CA2937611C (en) * 2014-02-27 2023-01-03 F. Hoffmann-La Roche Ag Modulation of cell growth and glycosylation in recombinant glycoprotein production
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
JP7313150B2 (ja) 2016-04-29 2023-07-24 イノベーション・ハマー・エルエルシー グリカンコンポジット配合物で光合成生物を処理し、収穫物の品質及び量を高めるための配合物及び方法
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
SG11202009216YA (en) * 2018-03-26 2020-10-29 Amgen Inc Total afucosylated glycoforms of antibodies produced in cell culture
JP2021524745A (ja) * 2018-05-24 2021-09-16 アレス トレーディング ソシエテ アノニム 糖タンパク質組成物の非フコシル化レベルを制御する方法
HUP1800376A2 (hu) 2018-11-07 2020-05-28 Richter Gedeon Nyrt Sejttenyészetben elõállított rekombináns glikoprotein glikozilációs-mintázatának megváltoztatására szolgáló módszer
TW202039849A (zh) * 2018-11-13 2020-11-01 美商健生生物科技公司 在產生抗cd38抗體之期間微量金屬的控制
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
JP2000517188A (ja) 1996-08-30 2000-12-26 ライフ テクノロジーズ,インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
EP1092037B1 (en) 1998-05-29 2005-12-28 Genentech, Inc. Cell culture process for producing glycoproteins
JP2001120262A (ja) 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
US6900056B2 (en) 2001-02-15 2005-05-31 Centocor, Inc. Chemically defined medium for cultured mammalian cells
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
CA2583027A1 (en) * 2004-11-02 2006-10-19 Ares Trading S.A. Serum-free cell culture medium for mammalian cells
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
CA2630811C (en) 2005-12-08 2016-05-31 Amgen Inc. Improved production of glycoproteins using manganese
CA2657248C (en) 2006-07-13 2018-10-30 Wyeth Production of glycoproteins
CA2666317C (en) 2006-11-03 2013-08-06 Wyeth Glycolysis-inhibiting substances in cell culture
DK2115126T3 (en) * 2007-03-02 2015-05-04 Wyeth Llc Use of copper and glutamate in cell culture for the preparation of polypeptides
US20110053223A1 (en) 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
US20120309056A1 (en) * 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
EP2563906B1 (en) 2010-04-26 2017-11-08 Novartis AG Process for cultivation of cho cells
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2012147048A2 (en) 2011-04-29 2012-11-01 Biocon Research Limited Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
EP2809773B1 (en) * 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CA2937611C (en) * 2014-02-27 2023-01-03 F. Hoffmann-La Roche Ag Modulation of cell growth and glycosylation in recombinant glycoprotein production

Also Published As

Publication number Publication date
CN106133146A (zh) 2016-11-16
US20170058309A1 (en) 2017-03-02
KR102280638B1 (ko) 2021-07-22
BR112016017660B1 (pt) 2022-04-19
PT3110961T (pt) 2020-01-29
LT3110961T (lt) 2020-02-10
CN106133146B (zh) 2021-05-04
JP2020054351A (ja) 2020-04-09
MX2016010236A (es) 2016-10-13
HRP20200100T1 (hr) 2020-04-03
ES2769003T3 (es) 2020-06-24
CA2937611A1 (en) 2015-09-03
SI3110961T1 (sl) 2020-03-31
EP3110961B1 (en) 2019-11-27
DK3110961T3 (da) 2020-02-03
KR20160125514A (ko) 2016-10-31
RU2016138176A (ru) 2018-03-29
EP3110961A1 (en) 2017-01-04
US20210222220A1 (en) 2021-07-22
RU2712562C2 (ru) 2020-01-29
RU2016138176A3 (hr) 2018-10-29
JP6934507B2 (ja) 2021-09-15
WO2015128314A1 (en) 2015-09-03
JP2017506515A (ja) 2017-03-09
PL3110961T3 (pl) 2020-04-30
RS59881B1 (sr) 2020-03-31
CA2937611C (en) 2023-01-03
HUE047575T2 (hu) 2020-04-28
JP6831702B2 (ja) 2021-02-17
BR112016017660A2 (hr) 2017-08-08
MX369395B (es) 2019-11-07

Similar Documents

Publication Publication Date Title
SG11201606856SA (en) Modulation of cell growth and glycosylation in recombinant glycoprotein production
HK1252582B (zh) 具有增强的細胞毒性的修飾的天然殺傷細胞和天然殺傷細胞系
IL253248A0 (en) Natural killer cells and their uses
IL258666A (en) Natural killer cells and ilc3 cells and their use
SG11201609118RA (en) Modified natural killer cells and uses thereof
HK1243444A1 (zh) 長效的ctp修飾的生長激素多肽的製備方法
HK1223980A1 (zh) 改進的重組多肽生產方法
HK1245297A1 (zh) 提高重組蛋白產量的方法
DK3242935T3 (da) O-glycansialylerede rekombinante glycoproteiner og cellelinjer til fremstilling deraf
HK1220492A1 (zh) 重組多肽生產
IL247776A0 (en) Methods for the production of substituted glycoproteins with adapted glycosylation
EP3322429B8 (en) Growth promoting peptides and uses thereof
SI3289088T1 (sl) Odklop rasti in proizvodnja proteina
HK1220991A1 (zh) 用於增加的重組蛋白產生的製劑和方法
PL3158055T3 (pl) Ulepszone wytwarzanie rekombinowanego czynnika von Willebranda w bioreaktorze
GB201308120D0 (en) Recombinant protein and method for its production
DE112015003749A5 (de) Peptid zur verwendung in der reduktion von nebenwirkungen in form von immunstimulatorischen reaktionen/effekten
GB201412354D0 (en) Improvements in and relating to loudspeakers
GB201408062D0 (en) Improvements in and relating to loudspeakers
GB201308218D0 (en) Chlor-Alkali Process and Plant